المؤلفون: Liu, X, George, GC, Tsimberidou, AM, Naing, A, Wheler, JJ, Kopetz, S, Fu, S, Piha-Paul, SA, Eng, C, Falchook, GS, Janku, F, Garrett, C, Karp, D, Kurzrock, R, Zinner, R, Raghav, K, Subbiah, V, Hess, K, Meric-Bernstam, F, Hong, DS, Overman, MJ

المصدر: BMC Cancer. 15(1)

مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Oncology and Carcinogenesis, Cancer, Digestive Diseases, Clinical Research, Colo-Rectal Cancer, Adult, Aged, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Cetuximab, Colorectal Neoplasms, Disease-Free Survival, ErbB Receptors, Erlotinib Hydrochloride, Female, Humans, Male, Middle Aged, Neoplasm Metastasis, Panitumumab, Proto-Oncogene Proteins p21(ras), Retreatment, Anti-EGFR treatment, KRAS-wt CRC, Public Health and Health Services, Oncology & Carcinogenesis, Oncology and carcinogenesis, Epidemiology

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/05594475

المؤلفون: Kainthla R, Kim KB, Falchook GS

المصدر: Pharmacogenomics and Personalized Medicine, Vol 2014, Iss default, Pp 21-29 (2013)

مصطلحات موضوعية: Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: http://www.dovepress.com/dabrafenib-for-treatment-of-braf-mutant-melanoma-a15416; https://doaj.org/toc/1178-7066

URL الوصول: https://doaj.org/article/7b2426800d994561a8f3aac6145248ca

المؤلفون: Park, H, Garrido-Laguna, I, Naing, A, Fu, S, Falchook, GS, Piha-Paul, SA, Wheler, JJ, Hong, DS, Tsimberidou, AM, Subbiah, V, Zinner, RG, Kaseb, AO, Patel, S, Fanale, MA, Velez-Bravo, VM, Meric-Bernstam, F, Kurzrock, R, Janku, F

المصدر: Oncotarget, vol 7, iss 41
Park, H; Garrido-Laguna, I; Naing, A; Fu, S; Falchook, GS; Piha-Paul, SA; et al.(2016). Phase I dose-escalation study of the mTOR inhibitor sirolimus and the HDAC inhibitor vorinostat in patients with advanced malignancy. ONCOTARGET, 7(41), 67521-67531. doi: 10.18632/oncotarget.11750. UC San Diego: Retrieved from: http://www.escholarship.org/uc/item/1dp7g79p

مصطلحات موضوعية: Sirolimus, Adult, Male, Vorinostat, Maximum Tolerated Dose, Adolescent, TOR Serine-Threonine Kinases, Oncology and Carcinogenesis, Middle Aged, phase I, Hydroxamic Acids, Histone Deacetylase Inhibitors, Young Adult, HDAC, hemic and lymphatic diseases, Neoplasms, Antineoplastic Combined Chemotherapy Protocols, mTOR, Humans, Female, Aged

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::512319f3ff14299dfb14919f0d8072de
https://escholarship.org/uc/item/1dp7g79p

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Falchook GS, Janku F, Tsao AS, Bastida CC, Stewart DJ, Kurzrock R, Falchook, Gerald S, Janku, Filip, Tsao, Anne S, Bastida, Christel C, Stewart, David J, Kurzrock, Razelle

المصدر: Journal of Thoracic Oncology; 2013 Feb, Vol. 8 Issue 2, pe19-20, 1p

المؤلفون: Duong B; Sarah Cannon Research Institute at HealthONE, Denver, CO, USA., Banskota P; Sarah Cannon Research Institute at HealthONE, Denver, CO, USA., Falchook GS; Sarah Cannon Research Institute at HealthONE, Denver, CO, USA.

المصدر: Journal of immunotherapy and precision oncology [J Immunother Precis Oncol] 2024 May 02; Vol. 7 (2), pp. 89-96. Date of Electronic Publication: 2024 May 02 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Innovative Healthcare Institute Country of Publication: United States NLM ID: 101768397 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-017X (Electronic) Linking ISSN: 2590017X NLM ISO Abbreviation: J Immunother Precis Oncol Subsets: PubMed not MEDLINE

المؤلفون: Falchook GS; Drug Development Unit, Sarah Cannon Research Institute at HealthONE, Denver, CO, USA. Gerald.Falchook@sarahcannon.com., Reeves J; Florida Cancer Specialists South, Sarah Cannon Research Institute, Fort Meyers, FL, USA., Gandhi S; Florida Cancer Specialists South, Sarah Cannon Research Institute, St. Petersberg, FL, USA., Spigel DR; Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN, USA., Arrowsmith E; Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN, USA., George DJ; Duke Cancer Institute, Durham, NC, USA., Karlix J; Sarah Cannon Research Institute, Gainesville, FL, USA., Pouliot G; Oncology R&D, AstraZeneca, Waltham, MA, USA., Hattersley MM; Oncology R&D, AstraZeneca, Waltham, MA, USA., Gangl ET; BioPharma R&D, AstraZeneca, Boston, MA, USA., James GD; Medical Statistics Consultancy Ltd, London, UK., Thompson J; Oncology R&D, AstraZeneca, Waltham, MA, USA., Russell DL; Oncology R&D, AstraZeneca, Waltham, MA, USA., Patel B; Oncology R&D, AstraZeneca, Cambridge, UK., Kumar R; Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Lim E; Medical Oncology & Hematology-LHCP, Corewell Health Medical Group, Grand Rapids, MI, USA.

المصدر: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Mar 02; Vol. 73 (4), pp. 72. Date of Electronic Publication: 2024 Mar 02.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Prostatic Neoplasms, Castration-Resistant* , Antineoplastic Agents*/therapeutic use , Antibodies, Monoclonal*, Male ; Humans ; Prostate-Specific Antigen ; Fatigue ; Adenosine ; Nausea/drug therapy

المؤلفون: Feustel K; Early Phase Clinical Trials Unit, Sarah Cannon Research Institute at HealthONE, Denver, CO, USA., Martin J; Rocky Vista University Medical School, Greenwood Village, CO, USA., Falchook GS; Early Phase Clinical Trials Unit, Sarah Cannon Research Institute at HealthONE, Denver, CO, USA.

المصدر: Journal of immunotherapy and precision oncology [J Immunother Precis Oncol] 2024 Feb 05; Vol. 7 (1), pp. 53-66. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Innovative Healthcare Institute Country of Publication: United States NLM ID: 101768397 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-017X (Electronic) Linking ISSN: 2590017X NLM ISO Abbreviation: J Immunother Precis Oncol Subsets: PubMed not MEDLINE

المؤلفون: Kuboki Y; National Cancer Center Hospital East, Kashiwa, Japan., Fakih M; City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Strickler J; Duke University Medical Center, Durham, NC, USA., Yaeger R; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Masuishi T; Aichi Cancer Center Hospital, Nagoya, Japan., Kim EJ; UC Davis Comprehensive Cancer Center, Sacramento, CA, USA., Bestvina CM; University of Chicago, Chicago, IL, USA., Kopetz S; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Falchook GS; Sarah Cannon Research Institute, Nashville, TN, USA., Langer C; University of Pennsylvania, Philadelphia, PA, USA., Krauss J; University of Michigan, Ann Arbor, MI, USA., Puri S; Huntsman Cancer Institute, Salt Lake City, UT, USA., Cardona P; Amgen Inc., Thousand Oaks, CA, USA., Chan E; Amgen Inc., Thousand Oaks, CA, USA., Varrieur T; Amgen Inc., Thousand Oaks, CA, USA., Mukundan L; Amgen Inc., Thousand Oaks, CA, USA., Anderson A; Amgen Inc., Thousand Oaks, CA, USA., Tran Q; Amgen Inc., Thousand Oaks, CA, USA., Hong DS; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. dshong@mdanderson.org.

المصدر: Nature medicine [Nat Med] 2024 Jan; Vol. 30 (1), pp. 265-270. Date of Electronic Publication: 2024 Jan 04.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Proto-Oncogene Proteins p21(ras)*/genetics , Proto-Oncogene Proteins p21(ras)*/metabolism , Colorectal Neoplasms*/drug therapy , Colorectal Neoplasms*/genetics , Colorectal Neoplasms*/pathology , Piperazines* , Pyridines* , Pyrimidines*, Humans ; Panitumumab/therapeutic use ; Antibodies, Monoclonal/adverse effects ; ErbB Receptors ; Mutation/genetics ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Dy GK; Roswell Park Comprehensive Cancer Center, Buffalo, NY., Govindan R; Siteman Cancer Center, Washington University School of Medicine, St Louis, MO., Velcheti V; Perlmutter Cancer Center, New York University Langone, New York, NY., Falchook GS; Sarah Cannon Research Institute at HealthONE, Denver, CO., Italiano A; Institut Bergonie, Bordeaux, France., Wolf J; Center for Integrated Oncology, University Hospital Cologne, Cologne, Germany., Sacher AG; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Takahashi T; Shizuoka Cancer Center, Shizuoka, Japan., Ramalingam SS; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA., Dooms C; University Hospitals KU Leuven, Leuven, Belgium., Kim DW; Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea., Addeo A; Hopitaux Universitaires de Geneve, Geneve, Switzerland., Desai J; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Schuler M; West German Cancer Center, University Hospital Essen, Essen, Germany., Tomasini P; Multidisciplinary Oncology and Therapeutic Innovations Department, Aix Marseille University, APHM, INSERM, NCRS, CRCM, Hôpital de la Timone, Marseille, France., Hong DS; The University of Texas MD Anderson Cancer Center, Houston, TX., Lito P; Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY., Tran Q; Amgen Inc, Thousand Oaks, CA., Jones S; Amgen Inc, Thousand Oaks, CA., Anderson A; Amgen Inc, Thousand Oaks, CA., Hindoyan A; Amgen Inc, Thousand Oaks, CA., Snyder W; Amgen Inc, Thousand Oaks, CA., Skoulidis F; The University of Texas MD Anderson Cancer Center, Houston, TX., Li BT; Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, New York, NY.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Jun 20; Vol. 41 (18), pp. 3311-3317. Date of Electronic Publication: 2023 Apr 25.

نوع المنشور: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics, Humans ; Kelch-Like ECH-Associated Protein 1 ; NF-E2-Related Factor 2 ; Proto-Oncogene Proteins p21(ras)/genetics